Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial

A neuroimaging biomarker for sustained experimental and clinical pain

(2021) Jae-Joong Lee et al.   NATURE MEDICINE

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

(2021) Anja Strangfeld et al.   ANNALS OF THE RHEUMATIC DISEASES

A New SARS CoV-2 Dual Purpose Serology Test: Highly Accurate Infection Tracing and Neutralizing Antibody Response Detection

(2021) Sean C. Taylor et al.   JOURNAL OF CLINICAL MICROBIOLOGY

COVID-19 vaccination and antirheumatic therapy

(2021) Jack Arnold et al.   RHEUMATOLOGY

Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases

(2021) Brian J Boyarsky et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases

(2021) Robert Spiera et al.   ANNALS OF THE RHEUMATIC DISEASES

AB0606 IMPACT OF ABDOMINAL AORTIC CALCIFICATION AND SERUM CREATININE-TO-CYSTATIN C RATIO TO BONE FRAGILITY FRACTURE

(2021) I. Yoshii   ANNALS OF THE RHEUMATIC DISEASES

AB0666 PROGNOSTIC VALUE OF SERUM KREBS VON DEN LUNGEN-6 GLYCOPROTEIN CIRCULATING LEVELS IN COVID-19 PNEUMONIA: A PROSPECTIVE COHORT STUDY

(2021) D. Lobo Prat et al.   ANNALS OF THE RHEUMATIC DISEASES

Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2

(2021) Yolanda Braun-Moscovici et al.   ANNALS OF THE RHEUMATIC DISEASES

LB0003 IMMUNOGENICITY AND SAFETY OF THE BNT162b2 mRNA COVID-19 VACCINE IN ADULT PATIENTS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES AND GENERAL POPULATION: A MULTICENTER STUDY

(2021) V. Furer et al.   ANNALS OF THE RHEUMATIC DISEASES

Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis

(2021) Serena Bugatti et al.   ANNALS OF THE RHEUMATIC DISEASES

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

(2021) Alejandro Jara et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly

(2021) Emire Seyahi et al.   RHEUMATOLOGY INTERNATIONAL

Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies

(2021) Laura Boekel et al.   Lancet Rheumatology

Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States

(2021) Rahul Raiker et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

(2020) Milena Gianfrancesco et al.   ANNALS OF THE RHEUMATIC DISEASES

Predictors of disease flare after discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab

(2020) Shuji Asai et al.   JOINT BONE SPINE

Weak correlation between antibody titers and neutralizing activity in sera from SARS‐CoV‐2 infected subjects

(2020) Elena Criscuolo et al.   JOURNAL OF MEDICAL VIROLOGY

Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial

(2019) Jin Kyun Park et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of short-term methotrexate discontinuation on rheumatoid arthritis disease activity: post-hoc analysis of two randomized trials

(2019) Jin Kyun Park et al.   CLINICAL RHEUMATOLOGY

Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial

(2018) Jin Kyun Park et al.   ANNALS OF THE RHEUMATIC DISEASES

The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis

(2015) Kevin L Winthrop et al.   ANNALS OF THE RHEUMATIC DISEASES

Low rates of biologic-free clinical disease activity index remission maintenance after biologic disease-modifying anti-rheumatic drug discontinuation while in remission in a Japanese multicentre rheumatoid arthritis registry

(2015) Kazuki Yoshida et al.   RHEUMATOLOGY

Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial

(2015) N. van Herwaarden et al.   BMJ-British Medical Journal

Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial

(2015) N. van Herwaarden et al.   BMJ-British Medical Journal

Construct and criterion validity of several proposed DAS28-based rheumatoid arthritis flare criteria: an OMERACT cohort validation study

(2012) Aatke van der Maas et al.   ANNALS OF THE RHEUMATIC DISEASES

Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice

(2011) A. C. M. Ribeiro et al.   ANNALS OF THE RHEUMATIC DISEASES

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

(2010) Daniel Aletaha et al.   ARTHRITIS AND RHEUMATISM

Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate

(2008) G Wells et al.   ANNALS OF THE RHEUMATIC DISEASES